basic sceince research

CLINICAL RESEARCH PROGRAM

Prostate Center of Excellence

The Center for Prostate Disease Research (CPDR) is a DoD research and clinical care center established by the U.S. Congress in 1992 to care for military service members and their families diagnosed with prostate cancer and prostate related disease. In 2010, CPDR received the prestigious distinction of being designated a DoD Prostate Center of Excellence. More recently, CPDR became a member of the Cancer Center of Excellence at Walter Reed-Bethesda (only DoD medical center to receive this distinction). In the past 20 years, the CPDR has grown into a robust program that is internationally recognized as a premier prostate patient care and research center.

 

MISSION

The CPDR Clinical Research Program mission is to provide state-of-the-art treatment and clinical research opportunities for military health care beneficiaries with prostate cancer and other prostate diseases.

Services Provided or Supported at our Clinical Center:

  • Multi-disciplinary Prostate Cancer Clinic for Newly Diagnosed Patients
  • Recurrent Prostate Cancer Clinic
  • Clinical Trial Services
  • Preoperative Counseling Class for Surgery Patients
  • Psychological Support
  • Nutrition Classes
  • Male Sexuality Issues
  • Monthly Support Groups
  • Numerous Patient Education Forums (Guest Speakers, Newsletters, and etc.)

State-of-the-art prostate cancer treatments:

  • Robotic-assisted laparoscopic prostatectomy
  • Intensity modulated Radiation Therapy w/ Image guided radiation therapy
  • Brachytherapy

 

Eligibility for Care

All Active Duty, Retirees, and their family members regardless of age.

CURRENT EVENTS


WRNMMC UsToo!

Read the FEBRUARY 2014 Newsletter

 

CURRENT PUBLICATIONS



Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer

Thangapazham R, Saenz F, Katta S, Mohamed AA, Tan S-H, Petrovics G, Srivastava S and Dobi A.
BMC Cancer. 2014: Jan 13;14:16.
Abstract



ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer.

Gsponer JR, Braun M, Scheble VJ, Zellweger T, Rentsch CA, Bachmann A, Perner S, Sesterhenn IA, Srivastava S, Dobi A, Bubendorf L, Ruiz C.
Prostate Cancer Prostatic Dis. 2014 Jan 28. doi: 10.1038/pcan.2013.62. [Epub ahead of print]
Abstract